Evidence map›Paper›PMID 30794557›Full record

ArticlePloS one2019

Extraction-free whole transcriptome gene expression analysis of FFPE sections and histology-directed subareas of tissue.

Christy L Trejo, Miloš Babić, Elliot Imler, Migdalia Gonzalez, Sergei I Bibikov, Peter J Shepard, Harper C VanSteenhouse, Joanne M Yeakley, Bruce E Seligmann

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Detection ofInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Christy L TrejoBioSpyder Technologies, Inc., Carlsbad, California, United States of America.ORCID 0000-0001-5535-3725
Miloš BabićBioSpyder Technologies, Inc., Carlsbad, California, United States of America.ORCID 0000-0002-4040-0370
Elliot ImlerBioSpyder Technologies, Inc., Carlsbad, California, United States of America.
Migdalia GonzalezBioSpyder Technologies, Inc., Carlsbad, California, United States of America.
Sergei I BibikovBioSpyder Technologies, Inc., Carlsbad, California, United States of America.
Peter J ShepardBioSpyder Technologies, Inc., Carlsbad, California, United States of America.
Harper C VanSteenhouseBioSpyder Technologies, Inc., Carlsbad, California, United States of America.
Joanne M YeakleyBioSpyder Technologies, Inc., Carlsbad, California, United States of America.ORCID 0000-0002-8500-0442
Bruce E SeligmannBioSpyder Technologies, Inc., Carlsbad, California, United States of America.ORCID 0000-0002-1342-801X

Funding

TempO-Seq for Preserved Tissues in Toxicity Testing Phase IIR44ES024107 · NIEHS · BIOSPYDER TECHNOLOGIES, INC. · PI SELIGMANN, BRUCE E. · 2017 to 2018
$1.5M
RASL-Seq Expression Profiling of FFPE TissuesR33CA183688 · NCI · BIOSPYDER TECHNOLOGIES, INC. · PI YEAKLEY, JOANNE MULLIGAN · 2015 to 2017
$1.0M
RASL-Seq for Preserved Tissues in Toxicity TestingR43ES024107 · NIEHS · BIOSPYDER TECHNOLOGIES, INC. · PI YEAKLEY, JOANNE MULLIGAN · 2014 to 2014
$150k
NCI NIH HHS R33 CA183688NIEHS NIH HHS R43 ES024107NIEHS NIH HHS R44 ES024107
6 · The paper itself

Abstract

We describe the use of a ligation-based targeted whole transcriptome expression profiling assay, TempO-Seq, to profile formalin-fixed paraffin-embedded (FFPE) tissue, including H&E stained FFPE tissue, by directly lysing tissue scraped from slides without extracting RNA or converting the RNA to cDNA. The correlation of measured gene expression changes in unfixed and fixed samples using blocks prepared from a pellet of a single cell type was R2 = 0.97, demonstrating that no significant artifacts were introduced by fixation. Fixed and fresh samples prepared in an equivalent manner produced comparable sequencing depth results (+/- 20%), with similar %CV (11.5 and 12.7%, respectively), indicating no significant loss of measurable RNA due to fixation. The sensitivity of the TempO-Seq assay was the same whether the tissue section was fixed or not. The assay performance was equivalent for human, mouse, or rat whole transcriptome. The results from 10 mm2 and 2 mm2 areas of tissue obtained from 5 μm thick sections were equivalent, thus demonstrating high sensitivity and ability to profile focal areas of histology within a section. Replicate reproducibility of separate areas of tissue ranged from R2 = 0.83 (lung) to 0.96 (liver) depending on the tissue type, with an average correlation of R2 = 0.90 across nine tissue types. The average %CVs were 16.8% for genes expressed at greater than 200 counts, and 20.3% for genes greater than 50 counts. Tissue specific differences in gene expression were identified and agreed with the literature. There was negligible impact on assay performance using FFPE tissues that had been archived for up to 30 years. Similarly, there was negligible impact of H&E staining, facilitating accurate visualization for scraping and assay of small focal areas of specific histology within a section.

Indexed as

AnimalsCell Line, TumorExome SequencingFormaldehydeGene Expression ProfilingGene Expression RegulationHumansMCF-7 CellsMiceParaffin EmbeddingRatsReproducibility of ResultsTissue FixationFormaldehyde

Identifiers

PMID30794557
PMCPMC6386473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.